Jasper Therapeutics Inc (JSPR) Insider Trading
- $9,592,289.50
- $359,812.55
- Sept. 22, 2025
- Jeetinder Singh Mahal
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 22, 2025 | Director | 20,000 | $2.43 | Buy | $48,600.00 | |
| Sept. 22, 2025 | CEO | 41,000 | $2.43 | Buy | $99,630.00 | |
| Sept. 22, 2025 | Director | 41,000 | $2.43 | Buy | $99,630.00 | |
| Sept. 22, 2025 | Director | 41,000 | $2.43 | Buy | $99,630.00 | |
| Dec. 12, 2024 | COO | 900 | $22.11 | Sell | $19,899.00 | |
| Sept. 12, 2024 | COO | 900 | $21.23 | Sell | $19,107.00 | |
| June 12, 2024 | COO | 900 | $24.16 | Sell | $21,744.00 | |
| March 12, 2024 | COO | 900 | $26.44 | Sell | $23,796.00 | |
| Feb. 8, 2024 | Major Shareholder | 350,000 | $12.95 | Buy | $4,532,500.00 | |
| Nov. 20, 2023 | Director | 10,000 | $0.63 | Buy | $6,300.00 | |
| Nov. 16, 2023 | Director | 10,000 | $0.60 | Buy | $6,000.00 | |
| Oct. 13, 2023 | Director | 7,965 | $0.85 | Sell | $6,770.25 | |
| June 13, 2023 | Insider | 9,000 | $1.66 | Sell | $14,940.00 | |
| April 14, 2023 | Director | 7,000 | $1.48 | Sell | $10,360.00 | |
| Jan. 27, 2023 | Major Shareholder | 3,133,333 | $1.50 | Buy | $4,699,999.50 | |
| Jan. 25, 2023 | Major Shareholder | 75,000 | $1.89 | Sell | $141,750.00 | |
| June 27, 2022 | Director | 24,743 | $2.08 | Sell | $51,465.44 | |
| June 24, 2022 | Director | 24,743 | $2.02 | Sell | $49,980.86 |
Insiders are both buying and selling Jasper Therapeutics Inc stock.
The insider traders at Jasper Therapeutics Inc are: Jeetinder Singh Mahal, Thomas G Wiggans, William Lis, Judith Anne Shizuru, Anna Louise French, Svetlana Lucas, Velan Capital Investment Manag, Ron Martell, Carlyle Group Inc., and Holding Ltd Roche
The most active insider trader at Jasper Therapeutics Inc is Jeetinder Singh Mahal with 5 trades.
Holding Ltd Roche has sold the most Jasper Therapeutics Inc stock with a total value of $283,500.00.
Carlyle Group Inc. has bought the most Jasper Therapeutics Inc stock with a total value of $9,399,999.00.
The most recent insider trade for Jasper Therapeutics Inc was on Sept. 22, 2025.
The single biggest insider buy for Jasper Therapeutics Inc was from Carlyle Group Inc. with a total value of $4,699,999.50 on Jan. 27, 2023.
The single biggest insider sell for Jasper Therapeutics Inc was from Holding Ltd Roche with a total value of $141,750.00 on Jan. 25, 2023.